Empagliflozin and Metformin (Synjardy)
Sodium-Glucose Cotransporter 2 Inhibitor class · 0 generic manufacturers · 0 ANDAs filed at FDA.
Questions a plan sponsor actually asks.
What is Empagliflozin and Metformin used for?
Empagliflozin and Metformin is a Sodium-Glucose Cotransporter 2 Inhibitor medication tracked in Medicare Part D.
Is there a generic for Empagliflozin and Metformin?
No. Empagliflozin and Metformin is brand-only with no generic equivalents currently in market.
How much does my plan pay for Empagliflozin and Metformin?
Across 329 Part D plans, Empagliflozin and Metformin averages $5.60/unit (NADAC). Lowest available: $5.60/unit. Highest in distribution: $5.62/unit.
Is Empagliflozin and Metformin on the FDA shortage list?
No. Empagliflozin and Metformin is not currently on the FDA Drug Shortage Database.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (8 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.